The economic impact of factor VIII inhib
β
R. L. Bohn; L. M. Aledort; K. G. Putnam; B. M. Ewenstein; H. Mogun; J. Avorn
π
Article
π
2004
π
John Wiley and Sons
π
English
β 61 KB
**Summary.** The impact on the cost of care for haemophilia patients with inhibitors is not well defined. To quantify the effect on health care expenditures associated with inhibitors to factor VIII (FVIII) or FIX, we conducted a retrospective cohort study examining product use and outcomes in adult